Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Glycolysis-enhancing α 1 -adrenergic antagonists modify cognitive symptoms related to Parkinson’s disease

medRxiv(2022)10.1101/2022.07.01.22277111Source: DataRank Database

Glycolysis-enhancing α 1 -adrenergic antagonists modify cognitive symptoms related to Parkinson’s disease is a research paper published in medRxiv (2022). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)OA: greenTopics (26)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Kartik Sivakumar,Ervina Tabakovic ORCID,Mayu Oya,Georgina M. Aldridge ORCID,Qiang Zhang ORCID

Live enrichment

PubMed:26207759 OpenAlex:https://openalex.org/W4283786184

National Institutes of Health

Grant: 5R01MH116043-05

Timing and dopamine in frontostriatal circuits

National Institutes of Health

Grant: 5R01NS120987-02

VTA dopamine neurons and cognitive symptoms of Parkinson’s disease

greenLicense: CC BY

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2022/07/02/2022.07.01.22277111.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2022.07.01.22277111

repositoryhttps://doi.org/10.1101/2022.07.01.22277111

https://doi.org/10.1038/s41531-023-00477-1

Fields of Study

Parkinson's Disease Mechanisms and TreatmentsNeuroscience and Neuropharmacology ResearchConducting polymers and applications03 medical and health sciences0302 clinical medicine

Keywords

TerazosinTyrosine hydroxylaseAdrenergicCognitive declineMedicineParkinson's diseaseInternal medicinePharmacologyDoxazosinCognitionDopaminePsychologyEndocrinologyDiseaseNeuroscienceDementiaReceptorBlood pressureNeurology. Diseases of the nervous systemRC346-429Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being